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Neutrophils require directional cues to navigate
through the complex structure of venular walls and
into inflamed tissues. Here we applied confocal intra-
vital microscopy to analyze neutrophil emigration in
cytokine-stimulated mouse cremaster muscles. We
identified differential and non-redundant roles for
the chemokines CXCL1 and CXCL2, governed by
their distinct cellular sources. CXCL1 was produced
mainly by TNF-stimulated endothelial cells (ECs)
and pericytes and supported luminal and sub-EC
neutrophil crawling. Conversely, neutrophils were
the main producers of CXCL2, and this chemokine
was critical for correct breaching of endothelial
junctions. This pro-migratory activity of CXCL2 de-
pended on the atypical chemokine receptor 1
(ACKR1), which is enriched within endothelial junc-
tions. Transmigrating neutrophils promoted a self-
guided migration response through EC junctions,
creating a junctional chemokine ‘‘depot’’ in the form
of ACKR1-presented CXCL2 that enabled efficient
unidirectional luminal-to-abluminal migration. Thus,
CXCL1 and CXCL2 act in a sequential manner to
guide neutrophils through venular walls as governed
by their distinct cellular sources.
INTRODUCTION
Neutrophils form the principal cellular arm of innate immunity
and are, as such, the host’s first line of protection in response
to infections and injury. Central to the neutrophils’ functions is1062 Immunity 49, 1062–1076, December 18, 2018 ª 2018 The Auth
This is an open access article under the CC BY license (http://creativetheir ability to rapidly exit the vascular compartment and migrate
within the extravascular tissue toward the core of an inflamma-
tory insult. This exquisitely coordinated behavior can be broadly
split into three stages: (1) neutrophil migratory responses on the
luminal aspect of venules, (2) migration through venular walls,
and finally, (3) directional interstitial motility (Nourshargh et al.,
2010). In line with the universally accepted concept of directed
cell migration, these phases of neutrophil movement are consid-
ered to be driven by locally presented chemotactic cues. Indeed,
there is ample evidence for the ability of chemokines to trigger
rapid integrin-mediated attachment to and crawling of neutro-
phils on venular endothelial cells (ECs) (Nourshargh and Alon,
2014). Furthermore, analysis of leukocytemotility within inflamed
tissues by confocal intravital microscopy (IVM) has revealed the
existence of multistep attraction cascades involving an ampli-
fying feed-forward mechanism as choreographed by different
types of chemoattractants (Kienle and L€ammermann, 2016). In
contrast to our understanding of luminal and tissue migratory re-
sponses, less is known about the nature and localization of
directional cues that guide neutrophils through the complex bi-
cellular structures of venular walls composed of ECs and peri-
cytes, a phenomenon that has been investigated here.
The exit of neutrophils from the vascular compartment re-
quires breaching of the venular endothelium, followed by
crossing the pericyte sheath that is embedded within the ven-
ular basement membrane (Nourshargh et al., 2010). Transendo-
thelial cell migration (TEM) commonly occurs in a paracellular
manner as mediated by junctionally expressed molecules
such as CD31, members of the junctional adhesion molecule
(JAM) family, VE-Cadherin, and CD99 (Nourshargh and Alon,
2014). Furthermore, once in the sub-EC space, neutrophils
exhibit significant crawling on pericyte processes, a response
that appears to represent the neutrophil’s quest for permissive
exit portals (Proebstl et al., 2012). Indeed, full breaching of ven-
ular walls predominantly occurs via gaps between adjacentors. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
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Figure 1. TNF-Induced Neutrophil Migration Is Dependent on Both CXCL1 and CXCL2
WT mice pre-treated intrascrotally (i.s.) with control (ctr) or blocking mAbs or Cxcr2/ mice were subjected to i.s. injections of PBS or TNF. The cremaster
muscles were immunostained for MRP14 (neutrophils) and a-SMA (pericytes) and analyzed for neutrophil infiltration by confocal microscopy. (A) and (C) are
representative images and (B), (D), and (E) show quantifications (n = 4–10 mice per group) from 5–6 independent experiments. Means ± SEM, ***p < 0.001 as
compared to TNF-treated ctrls and ###p < 0.001 as indicated. Scale bars, 30 mm. See also Figure S1.pericytes and regions within the venular basement membrane
that express reduced levels of certain matrix proteins (Proebstl
et al., 2012; Wang et al., 2006). Despite our growing under-
standing of the intricacies of neutrophil behavior within venular
walls, and certain aspects of the associated molecular machin-
ery, at present little is known about the patterning of directional
cues that sequentially guide neutrophils through the endothe-
lium and the pericyte layer. Here we set to define the molecular
determinants of neutrophil migration through ECs and pericytes
in inflamed cremaster muscles in vivo using high-resolution
confocal IVM. We found an absolute requirement for CXCR2
in TNF-induced neutrophil emigration and identified the two
CXCR2 ligands CXCL1 and CXCL2 as the principal directional
cues that mediate this response. Despite their highly homolo-
gous structures (90% in amino acid sequence), CXCL1 and
CXCL2 acted specifically and in a non-redundant and sequen-
tial manner to guide neutrophils through venular walls as gov-
erned by their distinct cellular sources. Of note, CXCL2
was almost exclusively derived from neutrophils, presenting
a paradigm whereby transmigrating neutrophils promote a
CXCL2-dependent self-guided migration response through
EC junctions. This mechanism entrails the ability of endothelial
atypical chemokine receptor 1 (ACKR1) enriched within
junctions to retain extrinsic CXCL2, thus creating a junc-
tional chemokine ‘‘depot’’ required for efficient unidirectional
luminal-to-abluminal neutrophil migration.RESULTS
TNF-InducedNeutrophilMigration IsDependent onBoth
CXCL1 and CXCL2
To investigate how directional cues guide neutrophils through
venular walls, we analyzed a robust acute inflammatory reaction
elicited by locally administered TNF within the mouse cremaster
muscle. Initial work aimed to identify the endogenous neutrophil
chemotactic cues generated in this model. We found that while
locally injected TNF (300 ng, 4 hr) induced a strong neutrophil
infiltration response in wild-type (WT) mice, this was totally in-
hibited in CXCR2-deficient animals (Figures 1A and 1B). Murine
CXCR2 is the receptor for several ELR+ chemokines, namely two
potent neutrophil chemoattractants (CXCL1 and CXCL2) as well
as CXCL3, CXCL5, and CXCL7 and a non-chemokine macro-
phage migration inhibitory factor (MIF) (Zlotnik and Yoshie,
2012). Co-injection of TNF with blocking mAbs against CXCL1
or CXCL2 led to >60% inhibition of neutrophil accumulation, as
compared to tissues injected with an isotype-matched control
mAb (Figures 1C and 1D). Co-injection of TNF simultaneously
with both anti-CXCL1 and anti-CXCL2 mAbs did not cause a
greater inhibition than that noted with either mAb alone (Fig-
ure 1D). Similar outcomes were observed in a TNF-induced peri-
tonitis model (Figure S1). Antibody blockade of two other CXCR2
ligands, CXCL5 andMIF, did not impact TNF-induced neutrophil
infiltration into cremaster muscles (Figure 1E).Immunity 49, 1062–1076, December 18, 2018 1063
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Figure 2. TNF-Elicited CXCL1 and CXCL2 Support Distinct Phases of Neutrophil-EC Interactions
Lyz2-EGFP-ki;Acta2-RFPcherry-Tgmice, subjected to in vivo CD31 labeling, were treated with ctr or blocking mAbs (i.v. 10 min prior to TNF in C and D and i.s.
100 min post TNF in E–H) and neutrophil responses in cremaster muscles injected locally with PBS or TNF quantified by confocal IVM.
(A) Illustrative images of the employed IVM model (scale bar, 20 mm).
(B) Scheme depicting neutrophil responses quantified in (C)–(H).
(C and D) Quantification of neutrophil adhesion and intraluminal crawling (n = 5–6 mice per group, 23 independent experiments).
(E) Time-lapse IVM images (Video S1) of a neutrophil TEM response in a TNF-stimulated tissue showing a neutrophil migrating from the lumen (0 min) through an
EC junction (2–4 min) into the sub-EC space (6 min). Representative of 11 independent experiments; cross sections, top; luminal views, bottom; scale bars, 5 mm.
(legend continued on next page)
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Collectively, these findings show that TNF-induced neutrophil
migration in vivo is dependent on the generation of CXCL1 and
CXCL2 in the tissue and involves signaling via their cognate re-
ceptor CXCR2. Because mAb blockade targeting either or both
chemokines simultaneously achieved the same level of inhibi-
tion, we hypothesized that CXCL1 andCXCL2may guide neutro-
phils through venular walls by acting sequentially along the cell
migratory pathway.
TNF-Elicited CXCL1 and CXCL2 Support Distinct
Phases of Neutrophil-EC Interactions
To explore the roles of TNF-induced endogenous CXCL1 and
CXCL2 in neutrophil migration through venular walls, the effects
of neutralizing mAbs on key phases were investigated by
confocal IVM. The latter is a model developed and optimized
for analyzing neutrophil-vessel wall interactions, enabling direct
and simultaneous tracking of neutrophil responses in relation to
ECs and pericytes in 3Dwith high spatiotemporal resolution (Fig-
ure 2A; Proebstl et al., 2012). We employed the compound re-
porter mouse Lyz2-EGFP-ki;Acta2-RFPcherry-Tg that displays
GFP+ myeloid cells and RFP+ smooth muscle cells and pericytes
(Proebstl et al., 2012), applying image capture settings that
selectively detect GFPbright neutrophils, and labeling EC junc-
tions in vivo using locally applied non-blocking Alexa Fluor
647-anti-CD31 mAb (Woodfin et al., 2011). Initially we investi-
gated the roles of CXCL1 and CXCL2 in early luminal responses
of neutrophil adhesion and crawling in post-capillary venules
(Figure 2B). With respect to both parameters, local injection of
TNF (300 ng; tissues imaged within the 2–4 hr in vivo test period)
induced significant responses as compared to PBS-treated tis-
sues (Figures 2C and 2D). Animals injected with intravenous
(i.v.) anti-CXCL1 mAb (10 min prior to administration of TNF)
exhibited significantly reduced neutrophil adhesion and crawl-
ing, as compared to mice treated with a control mAb (>62%
for both). In contrast, using the same protocol, CXCL2 blockade
had no significant effect on neutrophil adhesion or crawling (Fig-
ures 2C, 2D, S2A, and S2B).
After phases of luminal adhesion and crawling, neutrophils
breach the EC barrier by the active step of TEM (Nourshargh
and Alon, 2014). In line with our previous work (Woodfin et al.,
2011), neutrophil TEM was predominantly paracellular (i.e., via
EC junctions; 96%) and occurred rapidly (6 min) in a
luminal-to-abluminal direction (Figure 2E and Video S1). To
assess the roles of CXCL1 and CXCL2 in neutrophil TEM, we
tested locally applied blocking reagents in order to target post
luminal events. For this purpose, blocking or control mAbs
were injected intrascrotally (i.s.) 100 min post injection of TNF,
thus allowing the development of a robust initial adhesion and
diapedesis response.Within this model, anti-CXCL1mAbs again
suppressed luminal adhesion (37.7%) but also exerted a pro-
found inhibition of neutrophil TEM, as compared to responses
in control mAb-treated tissues (84% inhibition; Figure 2F).(F) Quantifications of neutrophil TEM (n = 4–11 mice per group, 27 independent
(G) IVM images (Video S2) of an aborted TEM response in a mouse treated with lo
protrusion through an EC junction (1min), retracting the protrusion, and re-enterin
sections and luminal views; scale bars, 5 mm.
(H) Quantification of aborted neutrophil TEM (n = 4–11 mice per group, 21 inde
compared to TNF-treated ctrls and ##p < 0.01, ###p < 0.001 as indicated. See aHowever, under these conditions, the fraction of neutrophils
that established a robust crawling response on ECs displayed
a similar percentage of neutrophil TEM to that noted in TNF-stim-
ulated tissues treated with a control mAb (17% and 25%,
respectively; Figure S2C). These results indicate that while
endogenous CXCL1 plays a critical role in supporting luminal
neutrophil firm adhesion, it does not mediate neutrophil TEM
per se, and as such, the inhibitory effect of the anti-CXCL1
mAb on TEM is due to suppression of preceding luminal re-
sponses. In contrast, but in agreement with the data obtained us-
ing i.v. anti-CXCL2 mAb, locally injected anti-CXCL2 mAb
exerted no suppression of neutrophil adhesion or luminal
crawling (data not shown) but induced almost total inhibition of
neutrophil TEM (Figure 2F). Indeed, in tissues treated with the
anti-CXCL2 mAb, a significant number of luminal neutrophils
initiated TEM by extending protrusions through EC junctions,
but then retracted and exhibited reverse motility back into the
blood circulation (Figures 2G and 2H; Video S2). This disrupted
mode of TEM that we have termed ‘‘aborted’’ TEM rarely
occurred in TNF-stimulated tissues treated with control or anti-
CXCL1 mAbs (2% and 8% of crawling neutrophils, respec-
tively) but was notably evident in tissues subjected to CXCL2
blockade (15% of crawling cells, p < 0.01, n = 5–10 mice per
group; Figure 2H). These results indicate an important role for
CXCL2 in providing directional cues for neutrophils within EC
junctions and hence mediating persistent migration of neutro-
phils from the apical to basolateral aspect of ECs in vivo.
Together, these data identify distinct roles for endogenously
generated CXCL1 and CXCL2 in neutrophil migration through
TNF-inflamed venular walls in vivo, supporting luminal neutro-
phil adhesion and crawling, and luminal-to-abluminal TEM,
respectively.
Neutrophil-Pericyte Interactions Are Selectively
Mediated by Endogenous CXCL1
Post TEM, neutrophils exhibit substantial sub-EC crawling on
pericyte processes before fully exiting the venular wall via gaps
between adjacent pericytes (Figures 3A and 3B; Video S3; Pro-
ebstl et al., 2012). To investigate the potential involvement of
CXCL1 and CXCL2 in this response, we injected blocking re-
agents locally, as employed for the analysis of neutrophil TEM.
As the anti-chemokine mAbs were injected 100 min post injec-
tion of TNF, the protocol enabled undisturbed passage of a large
number of neutrophils through the endothelium and into the sub-
EC space (average of 15 neutrophils per venular segment in all
conditions studied), allowing rigorous analysis of neutrophil-peri-
cyte interactions. Tracking of cells in the sub-EC space showed
that in contrast to control tissues, the majority of neutrophils in
anti-CXCL1 mAb-treated mice exhibited no crawling and indeed
appeared stationary during the observation period of 2 hr (Fig-
ures 3C and 3D). CXCL2 blockade exerted no such effect (Fig-
ure 3D). Furthermore, anti-CXCL1 mAb significantly reducedexperiments).
cal TNF+anti-CXCL2 mAb. The images show a luminal neutrophil extending a
g the circulation (5–8min). Representative of 6 independent experiments; cross
pendent experiments). Means ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001 as
lso Figure S2.
Immunity 49, 1062–1076, December 18, 2018 1065
A B
C D
E F G
H I
hr 
Figure 3. Neutrophil-Pericyte Interactions Are Selectively Mediated by Endogenous CXCL1
Lyz2-EGFP-ki;Acta2-RFPcherry-Tgmice, subjected to in vivo CD31 labeling, were stimulated locally with TNF and 100 min later i.s. injected with ctr or blocking
mAbs, as indicated.
(A) Neutrophil responses quantified in cremasteric venules by confocal IVM in (C)–(G).
(B) Representative confocal IVM luminal and cross-sectional views depicting a neutrophil localized between TNF-stimulated ECs and pericytes 1 min post TEM.
(C) Time-lapse IVM images (Video S3) showing a neutrophil crawling on pericytes (tracks, dashed lines) in a TNF-stimulated tissue (top) and the inhibition of this
response in tissues treated with anti-CXCL1 mAb (bottom).
Scale bars in (B) and (C), 10 mm.
(D–G) Crawling profiles of neutrophils on pericytes (20 cells per group for clarity) (D) as normalized for their origin and associated quantifications of displacement
(E), straightness index (displacement/track length) (F), and breaching of the pericyte layer (G).
(H) Time-lapse confocal IVM images (Video S4) illustrating neutrophil reverse TEM in a tissue treated with TNF+anti-CXCL1 mAb (luminal and cross-sectional
views; scale bars, 5 mm).
(I) Quantifications of neutrophil reverse TEM. Images are representative of 5–10 independent experiments and quantifications (n = 5–10mice per group) involve 20
independent experiments.
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Figure 4. Neutrophils Can Respond to Sequential Exposure to
CXCL1 and CXCL2
(A) Intracellular Ca2+ flux in neutrophils as induced by serial or single stimu-
lations with chemokines representative of 4 independent experiments.
(B) CXCL1 IF staining on Transwell filters coated with BSA or CXCL1 (n = 3)
from 3 independent experiments.
(C) Confocal images of GFP+ neutrophils seeded on BSA-, CXCL1-, or CXCL2-
coated Transwell filters representative of 3 independent experiments. Scale
bars, 10 mm.
(D–G) Chemotaxis of neutrophils exposed to immobilized CXCL1 or CXCL2
(D and E) or soluble CXCL1 or CXCL2 (F and G) into bottom chambers con-
taining indicated chemokines (1 hr at 37C; n = 4) from 2–4 independent ex-
periments. Means ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001 as compared to
corresponding responses without chemokines in bottom chambers and
###p < 0.001 as indicated.
See also Figure S3.the displacement (Figure 3E) and straightness index (displace-
ment/track length; Figure 3F) of sub-EC crawling neutrophils,
as compared to control mAb treatment, while CXCL2 blockade
failed to exert any such effects (Figures 3E and 3F).
The inhibitory impact of anti-CXCL1mAb on neutrophil motility
on pericytes resulted in a substantial retention of neutrophils
within venular walls with only a small fraction of neutrophils
breaching the pericyte layer as compared to responses quanti-
fied in control tissues (Figure 3G). However, the number of re-
tained neutrophils dropped gradually over the 2 hr observation
period as a significant fraction of neutrophils in the sub-EC space
reverse migrated through EC junctions and re-entered the blood
circulation (>25%; Figures 3H and 3I; Video S4). No such effect
was seen in anti-CXCL2 mAb-treated tissues.
Overall, these results demonstrate that TNF-induced CXCL1,
but not CXCL2, is an essential mediator of neutrophil motility
on pericytes and promotes neutrophil passage through the peri-
cyte layer, a critical step in neutrophil recruitment to inflamed tis-
sues (Proebstl et al., 2012).
Neutrophils Can Respond to Sequential Exposures to
CXCL1 and CXCL2
Having identified that neutrophil migration through venular walls
is mediated by sequential actions of CXCL1, CXCL2, and again
CXCL1, we sought to directly investigate the ability of neutrophils
in responding to serial activation of CXCR2 by these agonists.
Specifically, we wished to identify the conditions under which
neutrophils exposed to CXCL1 or CXCL2 could still sense gradi-
ents of the other chemokine. CXCR2 is a Gai-coupled receptor
and its ligation by corresponding agonists can trigger multiple
downstream signaling pathways including the activation of
PLCb and PI3Kg (Stadtmann and Zarbock, 2012). The former
elicits enhanced intracellular Ca2+ and diacylglycerol production
that are critical for rapid integrin activation and neutrophil arrest,
while activation of PI3Kg promotes AKT phosphorylation, a
signaling pathway required for chemotaxis (Stadtmann and Zar-
bock, 2012). Our initial studies showed that CXCL1 and CXCL2
are equipotent in stimulating mouse neutrophils to exhibit Ca2+
flux and adhesion to ICAM-1-coated plates (Figures S3A and
S3B). Both chemokines also stimulated neutrophil AKT phos-
phorylation and chemotaxis (Figures S3C and S3D). These
results are consistent with the fact that when administered exog-
enously, CXCL1 and CXCL2 can induce similar neutrophil trans-
migration responses (Zhang et al., 2001).
We next explored the ability of neutrophils to respond to
sequential stimulations by the two agonists under distinct condi-
tions of CXCL1 and CXCL2 encounter. Initially, aiming to mimic
the cascade of responses noted in vivo, Fluo-4-loaded bone
marrow neutrophils were treated in a consecutive manner with
CXCL1, CXCL2, and finally with CXCL1 again. The subsequent
exposure to the same concentration of agonist resulted in
notably reduced Ca2+ signals as compared to responses de-
tected in cell samples stimulated with one agonist only (data
not shown). In contrast, with increasing concentrations of ago-
nists, neutrophils were able to exhibit robust, rapid, and transient
increases in intracellular Ca2+ following serial activations (Fig-
ure 4A). However, as found before, cells stimulated with soluble
CXCL1 and/or CXCL2 showed reduced intracellular Ca2+ flux to
subsequent agonist stimulations, as compared to responsesImmunity 49, 1062–1076, December 18, 2018 1067
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Figure 5. CXCL1 and CXCL2 Are Differentially Expressed in TNF-Stimulated Tissues
(A–E) WT mice were treated i.s. with PBS or TNF and cremaster muscles were IF stained for CXCL1 or CXCL2 and CD31 (ECs), a-SMA (pericytes), and MRP14
(neutrophils). Representative confocal images of venules showing CXCL1 (A) or CXCL2 (C) staining within EC and pericyte isosurface masks and quantifications
(legend continued on next page)
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elicited following a single chemokine exposure (Figure S3E). To
further mimic the in vivo scenario, and in line with the accepted
paradigm that luminal neutrophil adhesion and crawling is medi-
ated by chemokines expressed on the cell surface of ECs (Nour-
shargh and Alon, 2014), we tested the impact of immobilized
CXCL1 on CXCL2-induced neutrophil chemotaxis. GFP+ neutro-
phils (isolated from Lyz2-EGFP-ki mice) were seeded onto
Transwell filters coated with either BSA or CXCL1, and the
bottom chambers were filled with medium containing CXCL2
(0.1–10 nM). The presentation of biologically active CXCL1 on
chemokine-coated filters was confirmed by immunofluores-
cence (IF) staining and the flattened morphology of neutrophils,
as compared to BSA-coated filters (Figures 4B and 4C). Strik-
ingly, neutrophils migrating through BSA- and CXCL1-coated
filters exhibited identical chemotactic responses to CXCL2 (Fig-
ure 4D). Similarly, exposure of neutrophils to immobilized CXCL2
(presentation and activity again confirmed by IF staining and
neutrophil morphology; Figures S3F and 4C) did not affect
neutrophil chemotaxis into CXCL1-containing bottom chambers
(Figure 4E). In contrast, and in line with our Ca2+ flux data, neu-
trophils exposed to soluble CXCL1 or CXCL2 (both 10 nM) in
the upper chamber of Transwell plates showed profoundly sup-
pressedmigration to either CXCL2 or CXCL1, respectively, in the
lower chamber (Figures 4F and 4G).
Collectively, the data illustrate that neutrophils are able to
respond to sequential stimulations by CXCL1 and CXCL2, espe-
cially when the first chemokine is in an immobilized state. Thus,
the distinct and sequential roles of these chemokines in guiding
neutrophils through venular walls in vivo may be governed by
their potentially differential temporal and spatial presentation to
migrating neutrophils.
CXCL1 and CXCL2 Are Differentially Expressed in TNF-
Stimulated Tissues
To investigate the cellular source and distribution of CXCL1 and
CXCL2generatedwithin TNF-stimulated venules, in initial studies,
permeabilized whole-mounted tissues were analyzed by IF stain-
ing. While control PBS-treated tissues showed almost no CXCL1
signal in CD31-labeled ECs and a-SMA-stained pericytes (also
identified by their morphology and anatomical location), CXCL1
expression was notably enhanced in both cell types in TNF-stim-
ulated samples (Figures 5A and 5B). This staining was in a punc-
tate pattern, an expression profile that may represent intracellular
CXCL1 vesicular depots en route to secretion and/or cell surface
presentation, and in ECs appeared evenly distributed in junctional
and non-junctional regions (mean fluorescence intensity [MFI] of
CXCL1 IF staining: 4.9 and 4.6, respectively, n = 3; Figure S4A).
ThevesicularprofileofCXCL1 is inagreementwithpreviousworks
reporting intracellular chemokine puncta in the context of CCL2 inof CXCL1 (B) and CXCL2 (D) in ECs or pericytes, in terms of MFIs (n = 4 mice p
sectional images (acquired along the dashed line and presented at 90 rotation
experiments.
(F)Cxcl1 andCxcl2mRNA levels relative toGapdh in circulating neutrophils 2–3 hr
group, 2 independent experiments).
(G–J) Purified mouse bone marrow neutrophils were treated with PBS or TNF (1 n
and/or CXCL2 levels in lysates (G and I) and supernatants (H and J) as quantified b
**p < 0.01, ***p < 0.001 as compared to corresponding PBS-treated ctrls and #p
See also Figure S4.TNF-stimulated ECs (Shulman et al., 2011) and CCL21 in
lymphatic ECs (Vaahtomeri et al., 2017). In contrast to CXCL1,
CXCL2 was hardly detectable in venular ECs and pericytes in
both control and TNF-stimulated tissues (Figures 5C and 5D).
Furthermore, in TNF-stimulated tissues, vascular wall cells were
an abundant source of Cxcl1 (but not Cxcl2) mRNA expression
in vivo, as detected and quantified byRNA fluorescence in situ hy-
bridization (FISH; FiguresS4B–S4E).SinceCxcl1geneexpression
in stimulatedECs has previously been reported (Chou et al., 2010;
Li et al., 2016), we sought further evidence for the striking differ-
ences between the cellular localization of CXCL1 and CXCL2 in
the context of pericytes. For this purpose, we established a
method of isolating and culturing venular cremaster muscle peri-
cytes from Acta2-RFPcherry-Tg mice (Figures S4F and S4G). In
line with our in vivo results, TNF stimulation (4 hr) of cultured peri-
cytes led to a robust release of CXCL1but low levels of CXCL2, as
analyzed by ELISA (Figure S4H).
While collectively these results provided conclusive evidence
for CXCL1, but not CXCL2, being predominantly derived from
ECs and pericytes, the cellular source of CXCL2 within venular
walls remained elusive. Here, as IF stainings indicated abundant
expression of CXCL2 in luminal neutrophils in TNF-stimulated
tissues (Figure 5E), we extended this observation to mRNA
(real-time PCR) and protein (ELISA) analysis of CXCL2, as
compared to CXCL1, using isolated murine neutrophils. While
blood neutrophils obtained from control PBS-stimulated mice
showed low Cxcl1 and Cxcl2 mRNA levels, neutrophils isolated
frommice subjected to local i.s. TNF (2–3 hr) exhibited strong in-
duction of Cxcl2, but not Cxcl1, mRNA (Figure 5F). In contrast,
Cxcl1 (but not Cxcl2) transcripts were strongly increased in
cultured cytokine-stimulated lung ECs and primary cremaster
muscle pericytes (12- and 47-fold increase, as compared to
unstimulated cells, respectively). In line with the mRNA results,
analysis of protein levels by ELISA in supernatants and cell ly-
sates derived from unstimulated and TNF-stimulated (1 nM,
1 hr) neutrophils revealed low levels of CXCL1 (Figures 5G and
5H). In contrast, mouse neutrophils expressed CXCL2 under
basal conditions (potentially in pre-formed stores) that was
further increased in TNF-stimulated cells (Figures 5G and 5H).
Furthermore, TNF-stimulated neutrophils seeded on immobi-
lized CXCL1 showed an even greater increase in levels of cell-
associated and released CXCL2, as compared to TNF-treated
cells placed onto immobilized BSA (Figure 5I and 5J). These find-
ings support the notion that CXCL1 derived from TNF-stimulated
ECs and presented to neutrophils on the luminal aspect of the
endothelium can promote CXCL2 generation and release by
adherent and/or crawling neutrophils.
Collectively, these data show differential sources of CXCL1
and CXCL2 in inflamed venules, with CXCL1 being primarilyer group) from 4 independent experiments. (E) Confocal abluminal and cross-
) of a venule showing overall CXCL2 staining representative of 4 independent
after i.s. PBS or TNF injection as determined by real-time PCR (n = 4–5mice per
M, 1 hr) on uncoated (G, H), BSA-coated, or CXCL1-coated wells (I, J). CXCL1
y ELISA (n = 4–12) from 2–4 independent experiments. Means ± SEM, *p < 0.05,
< 0.05, ##p < 0.01, ###p < 0.001, as indicated. Scale bars, 5 mm.
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produced by ECs and pericytes and CXCL2 being expressed
and secreted by stimulated neutrophils.
CXCL2 Mediates Neutrophil TEM in a Cell-Autonomous
Manner and Is Retained at EC Junctions via the Atypical
Chemokine Receptor ACKR1
As endogenous CXCL2 plays a vital role in supporting luminal-to-
abluminal neutrophil TEM (Figures 2E–2H) and a rich source of
this chemokine are TNF-stimulated neutrophils (Figures 5E–
5H), we sought to investigate the role of neutrophil-derived
CXCL2 in neutrophil transmigration. For this purpose, we gener-
ated leukocyte CXCL2-deficient (Cxcl2/) and control (WT) chi-
meras by transferring bone marrow cells from Cxcl2/ or WT
mice, respectively, into lethally irradiated Lyz2-EGFP-ki recipi-
ents. Initial control studies demonstrated that CXCL2-express-
ing andCxcl2/ neutrophils show similar chemotaxis responses
in an in vitro assay (Figure S5A). In TNF-stimulated cremaster
muscles, Cxcl2/ chimeras exhibited comparable levels of
neutrophil adhesion but significantly reduced neutrophil extrav-
asation, as compared toWT chimeras (Figures 6A–6C). Similarly,
Cxcl2/ chimeras showed reduced TNF-induced neutrophil
(but not monocyte) extravasation into peritoneal cavities and
decreased neutrophil infiltration in a lipopolysaccharide (LPS)-
driven cutaneous inflammation model (Figures S5B–S5D). To
gain greater insight into themechanism throughwhich neutrophil
CXCL2 promotes neutrophil migration, we generated mixed
chimeric mice that expressed both Cxcl2/ andGFP-Cxcl2wt/wt
neutrophils. Here, direct comparison of Cxcl2/ and GFP-
Cxcl2wt/wt neutrophils within TNF-stimulated cremaster muscles
showed a significantly reduced transmigration response of the
Cxcl2/ cells (Figure 6D). Together, these findings provide
direct evidence for the ability of neutrophil-derived CXCL2 to
mediate neutrophil TEM and suggest that this response is, at
least partly, mediated in a self-guided autocrine manner.
In aiming to ascertain whether the binding of neutrophil-
derived CXCL2 to ECs was a component of its functionality,
we investigated the binding profile of locally applied recombi-
nant murine (rm)CXCL2 in cremaster muscles. IF staining of per-
meabilized tissues showed remarkably selective binding of
rmCXCL2 to venular ECs with negligible binding to arteriolar
and capillary ECs (Figures 6E, 6F, and S5E). Of note, rmCXCL2
binding was co-localized with CD31hi regions, indicating enrich-Figure 6. CXCL2 Mediates Neutrophil TEM in a Cell-Autonomous Ma
Receptor ACKR1
(A–C) Representative confocal images of venules in TNF-stimulated cremaster mu
for a-SMA andMRP14 (A) and associated quantifications of neutrophil adhesion a
Scale bars, 30 mm.
(D) Numbers of extravasated GFP-Cxcl2wt/wt and Cxcl2/ neutrophils in TNF-s
numbers in the blood (n = 4 mice, 3 independent experiments).
(E–G) RmCXCL2 or rmCXCL1 was injected i.s. into WT mice and cremaster mu
confocal microscopy. Images (E; representative of 4 independent experiments;
microcirculation (F, n = 3–8 mice per group, 8 independent experiments), and en
(H and I) Cremaster muscles were stimulated with PBS or TNF and IF stained for
5 mm) and quantification of ACKR1 localization (I, n = 4 mice per group, 4 indepe
(J–L) IF localization of rmCXCL2 and rmCXCL1 in cremasteric venules in relation t
Ackr1/ mice injected with rmCXCL2 (J; scale bars, 5 mm) and quantifications
independent experiments). (L) CXCL2, ACKR1, and CD31 IF intensities along th
dependent experiments). Means ± SEM, *p < 0.05, **p < 0.01 (as compared to a
See also Figure S5.ment at EC junctions (Figures 6E and 6G). In contrast, exogenous
rmCXCL1 exhibited only marginal binding to venules and
showed no indications of junctional enrichment (Figure 6F and
S5E). As the junctional binding profile of rmCXCL2 is consistent
with the functional role of CXCL2 in mediating neutrophil TEM,
we sought to investigate the mechanism through which soluble
CXCL2 is retained at EC junctions. Here, we focused our atten-
tion on the atypical chemokine receptor ACKR1 which binds
CXCL2 and numerous other CXC and CC chemokines with
high affinity (Nibbs and Graham, 2013; Novitzky-Basso and
Rot, 2012). ACKR1 expression has recently been comprehen-
sively studied in the murine microcirculation, identifying it as a
specific marker of venular ECs in multiple tissues (Thiriot et al.,
2017). We confirmed this in our system and showed additionally
that irrespective of TNF treatment, ACKR1 expression was
exclusively venular within themouse cremaster muscle microcir-
culation (Figure S5F). Notably, ACKR1 expression was enriched
at EC junctions (as identified by VE-Cadherin staining) and no
change in the profile or magnitude of this expression was noted
in inflamed tissues (Figures 6H and 6I). A junctional expression
profile for ACKR1 was also observed in the ear dermal microcir-
culation of WT mice but not Ackr1/mice, confirming the spec-
ificity of our anti-ACKR1 mAb (Figure S5G). We next sought to
investigate the possibility that ACKR1may support EC junctional
retention of CXCL2. Indeed, the venular binding of rmCXCL2 (but
not rmCXCL1) was totally dependent on ACKR1 as indicated by
its lack of binding in tissues ofAckr1/mice (Figures 6J and 6K).
Detailed analysis of ACKR1 expression and the binding pattern
of exogenous rmCXCL2 showed clear EC junctional association
of both molecules as demonstrated by their overlap with EC
CD31hi regions (Figure 6L).
Together these data provide quantitative evidence for en-
riched ACKR1 expression at EC junctions and show that this
expression pattern allows ACKR1 to retain non-EC-derived
CXCL2 at EC junctions.
Endothelial ACKR1 Facilitates Decisive Luminal-to-
Abluminal Neutrophil TEM
Next, we sought to investigate the functional role of EC ACKR1 in
neutrophil TEM in vivo. Initial IF staining revealed that in TNF-
stimulated venules, neutrophils breached EC junctions in close
apposition to regions of high ACKR1 expression. Notably, whilenner and Is Retained at EC Junctions via the Atypical Chemokine
scles of control (WT) or leukocyte CXCL2-deficient (Cxcl2/) chimeras stained
nd extravasation (B, C; n = 4mice per group) from 4 independent experiments).
timulated cremaster muscles of mixed chimeras, as normalized for neutrophil
scles were stained for CXCL2 or CXCL1, CD31, and MRP14 and analyzed by
scale bar, 5 mm), quantified localization of rmCXCL2 or rmCXCL1 within the
larged images of the boxed region in (E) (G; scale bar, 2 mm).
ACKR1, VE-Cadherin, and MRP14. Confocal images of venules (H; scale bars,
ndent experiments).
o ACKR1 expression. Representative confocal images of tissues from WT and
of endothelial rmCXCL2 and rmCXCL1 binding (K, n = 4–5 mice per group, 3
e dashed line in (E) cutting across 4 EC junctions (Jn; representative of 4 in-
rterioles or capillaries in F and non-junctional ACKR1 expression in I).
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Figure 7. Endothelial ACKR1 Facilitates
Decisive Luminal-to-Abluminal TEM
(A) Confocal images showing a neutrophil (arrow)
migrating through an EC junction in a TNF-stimu-
lated cremasteric venule of a WTmouse IF stained
for MRP14, VE-Cadherin, and ACKR1. Luminal
(top) and cross-sectional images (bottom) along
dashed line; representative of 3 independent ex-
periments; scale bars, 5 mm.
(B) Scheme illustrating the generation of chimeric
mice exhibiting Lyz2-EGFP-ki hematopoietic cells
(GFP+ neutrophils) and WT or Ackr1/ non-he-
matopoietic cells.
(C–F) Quantification of neutrophil extravasation
(C), adhesion to ECs (D), initiating TEM (E), and
undergoing complete or aborted TEM (F) in cre-
master muscles of WT and Ackr1/ chimeras af-
ter local PBS or TNF injection (n = 3–8 mice per
group, 26 independent experiments) as analyzed
by confocal IVM. Means ± SEM, *p < 0.05,
***p < 0.001 relative toWT chimeras and #p < 0.05,
##p < 0.01, ###p < 0.001 as indicated.
See also Figure S6.VE-Cadherin was displaced during neutrophil TEM, ACKR1
formed ring-like structures around leading edge protrusions of
transmigrating neutrophils (Figure 7A). This supports the notion
that neutrophils may sense chemokines within EC junctions as
immobilized by ACKR1. Unlike other ACKRs (Nibbs andGraham,
2013), ACKR1 does not scavenge its cognate chemokines but
supports their functions, including facilitating chemokine-medi-
ated leukocyte emigration (Pruenster et al., 2009). However,
the mechanism by which EC ACKR1 achieves this has not1072 Immunity 49, 1062–1076, December 18, 2018been studied in vivo. To directly investi-
gate the role of EC ACKR1, chimeric
mice were generated by bone-marrow
transfer from Lyz2-EGFP-ki mice to
lethally irradiated control mice (WT chi-
meras) and Ackr1/ mice (Ackr1/
chimeras; deficient in EC ACKR1)
(Figure 7B). We compared migratory re-
sponses of GFP+ neutrophils in CD31-
labeled inflamed cremaster muscles of
these mice by confocal IVM. Total
neutrophil extravasation was significantly
reduced in TNF-stimulated tissues of
mice deficient in EC ACKR1 (48%; Fig-
ure 7C). This, however, was not associ-
ated with reduced luminal neutrophil
adhesion, which was not significantly
different between WT and Ackr1/
chimeric animals (Figure 7D). Further-
more, analysis of neutrophil TEM re-
vealed that the number of neutrophils
extending a protrusion through CD31-
labeled EC junctions and creating a
notable pore, i.e., initiating TEM, was
similar in WT and Ackr1/ chimeras (Fig-
ure 7E). However, in EC ACKR1-deficient
animals, >40% of neutrophils thatentered EC junctions exhibited aborted TEM, reversed their
migratory direction, and re-entered the blood circulation. In
contrast, WT chimeras showed only <10% of such disrupted
mode of TEM (Figure 7F). Similar to findings with TNF, Ackr1/
chimeras treated intrascrotally with IL-1b showed no defect in
neutrophil adhesion, but had reduced TEM and increased
aborted TEM, as compared to WT chimeras (Figures S6A and
S6B). Furthermore, Ackr1/ chimeras exhibited reduced tissue
infiltration of neutrophils in a TNF-driven peritonitis model
(Figure S6C) and inmodels of cutaneous inflammation as elicited
by local injection of TNF or LPS (Figure S6D and S6E). Of note,
TNF-induced monocyte migration into the peritoneal cavity
was also decreased in Ackr1/ chimeras (Figure S6F), suggest-
ing a role for EC junctional ACKR1 in retention of monocyte re-
cruiting chemokines (e.g., CCL2) and hence monocyte TEM.
Collectively these results identify a function for EC ACKR1 as a
receptor pivotal for retaining extrinsic chemokines at EC
junctions and as such supporting persistent directional neutro-
phil migration through EC junctions in a luminal-to-abluminal
manner.
DISCUSSION
Despite our growing understanding of the cellular and molecular
events that support leukocyte trafficking, details of the pro-
migratory mechanisms that guide leukocytes through the com-
plex bi-cellular and 3D structure of venular walls remains
unclear. Here, we demonstrate that the passage of neutrophils
from the bloodstream to the interstitial tissue is governed by
the existence of sequentially expressed and molecularly distinct
‘‘chemotactic depots’’ that are presented to neutrophils on the
luminal aspect of the endothelium, within EC junctions, and in
the pericyte layer. These consecutive pro-migratory signals are
established through cell-specific generation of defined chemo-
kines and the existence of functionally pivotal retention mecha-
nisms. The delineation of distinct cellular and molecular
compartments within venular walls provides a paradigm for
regulation of efficient and persistent neutrophil transmigration.
Although the scope of chemokine functions now extends well
beyond their original characterization as leukocyte chemoattrac-
tants, chemokines remain among the most potent and versatile
pro-migratory mediators of in vivo leukocyte migration and traf-
ficking. With respect to neutrophils, the ELR+ CXC chemokines,
humanCXCL8 (IL-8), and itsmurine functional homologs, CXCL1
(KC) and CXCL2 (MIP-2), are among the most effective drivers of
neutrophil migration into inflamed tissues (Griffith et al., 2014).
The principal receptors for ELR+ CXC chemokines are CXCR1
and CXCR2, with the latter being of particular interest due to
its direct association with numerous acute inflammatory pathol-
ogies (Stadtmann and Zarbock, 2012). The essential involvement
of CXCR2 in supporting acute neutrophil trafficking is well estab-
lished but the precise roles of its multiple ligands (i.e., CXCL1,
CXCL2, CXCL3, CXCL5, CXCL7, and MIF) remain unclear with
suggestions of functional overlap or redundancy. Here, within a
CXCR2-dependent inflammatory model, we identified distinct,
sequential, and functionally non-redundant roles for endoge-
nously generated CXCL1 and CXCL2 in driving neutrophil migra-
tion through venular walls. Specifically, TNF-induced CXCL1
mediated neutrophil adhesion and intraluminal crawling on in-
flamed ECs and sub-EC crawling on pericytes, whereas
CXCL2 supported neutrophil breaching of EC junctions. Mecha-
nistically, this was attributed to the defined cellular sources of
CXCL1 and CXCL2 in that TNF-activated ECs and pericytes
selectively generated CXCL1, while CXCL2 was derived primar-
ily from neutrophils. This disparate profile of CXCL1 and CXCL2
sources is in line with similar observations stemming from other
inflammatory models indicating relatively restricted expression
of CXCL1 to vascular and tissue-resident cells, and associatingCXCL2, but not CXCL1, with activated neutrophils (Li et al.,
2016). Nevertheless, CXCL1 and CXCL2 injected into tissues
are often used interchangeably to induce neutrophil migration
in vivo, and indeed both have been shown to activate all the
steps of the leukocyte adhesion cascade (Zhang et al., 2001).
However, in agreement with our findings, endogenously pro-
duced CXCL1 and CXCL2 can exhibit distinct functional profiles
in different experimental models (Armstrong et al., 2004; Li et al.,
2016; Chou et al., 2010), demonstrating the existence and
indeed strength of sequential cascades of pro-inflammatory
mediators in development of neutrophilic inflammation (Sadik
et al., 2011).
The ability of EC- and pericyte-associated CXCL1 in support-
ing neutrophil crawling and adhesion is well in line with the
essential role of CXCR2 in activating b2-integrin inside-out
signaling (Lefort and Ley, 2012).Mechanistically, both stimulated
ECs and pericytes exhibit enhanced ICAM-1 expression (Pro-
ebstl et al., 2012) and as such neutrophil crawling on these cells
is ICAM-1 dependent (Phillipson et al., 2006; Proebstl et al.,
2012). Of note, the importance of pericyte-associated CXCL1
in maintaining persistent and unidirectional movement of neutro-
phils through venular walls was dramatically illustrated by the
occurrence of neutrophil reverse motility within venular walls,
and ultimately re-entry back into the vascular lumen, under con-
ditions of CXCL1 blockade. We have previously associated such
neutrophil reverse TEM (rTEM) with inflammatory conditions
exhibiting neutrophil elastase (NE)-mediated cleavage of EC
JAM-C (Colom et al., 2015; Woodfin et al., 2011). JAM-C expres-
sion is not, however, regulated during TNF-induced inflamma-
tion and both TNF and CXCL1 are not effective inducers of NE
release from neutrophils (data not shown). Thus, altered expres-
sion of JAM-C does not account for the aberrant modes of
neutrophil TEM noted in the present study. The CXCL1 depen-
dency of luminal neutrophil responses and neutrophil-pericyte
interactions may, however, be supported by the retention of
EC- and pericyte-derived CXCL1 by cell surface glycosamino-
glycans (GAGs) that characteristically retain cell-autonomous
chemokines (Proudfoot et al., 2017).
Within the peripheral circulation, migration of leukocytes
through the endothelium typically occurs via contacts between
adjacent ECs as facilitated by numerous junctionally presented
adhesion molecules (Nourshargh and Alon, 2014). Although our
understanding of the expression and function of such molecules
is growing (Reglero-Real et al., 2016), less is known about the
patterning of directional cues that govern neutrophil protrusion
through junctions and breaching of the endothelium. Here we
show that local blockade of CXCL2, but not CXCL1, resulted in
an aborted mode of neutrophil transit through EC junctions
and reverse motility of neutrophils back into the vascular lumen.
The use of chimeric mice and mixed chimeric mice deficient in
leukocyte CXCL2 provided compelling evidence to suggest the
establishment of a cell-autonomous neutrophil chemotaxis
response within EC junctions. Neutrophils are known to be a
rich source of chemokines that can be released by a broad range
of stimuli in vitro (Tecchio and Cassatella, 2016) and indeed
neutrophil-derived chemokines and other chemoattractants
can act in a feed forward loop to support neutrophil migration
and swarming in interstitial tissues, as well as the migration of
other leukocyte sub-types into inflammatory sites (Chou et al.,Immunity 49, 1062–1076, December 18, 2018 1073
2010; L€ammermann et al., 2013; Li et al., 2016; Lim et al., 2015).
In identifying a role for neutrophil-derived CXCL2 in neutrophil
TEM, our results reveal a function of leukocyte-derived chemo-
kines, and potentially other chemotactic agents, in facilitating
immune cell breaching of EC junctions. Mechanistically, we
noted that cell-extrinsic CXCL2 (but not CXCL1) selectively
bound to venular ECs in a manner entirely dependent on the
atypical chemokine receptor ACKR1. Members of this family
are structurally similar to signaling chemokine G protein-coupled
receptors (GPCRs), but while they are unable to trigger signaling
pathways characterized by classical chemokine receptors,
ACKRs play critical roles in retention, transport, and clearance
of chemokines (Nibbs and Graham, 2013). ACKR1 can bind
CXCL2 and >20 other chemokines and whereas its expression
in erythroid lineage regulates hematopoiesis (Duchene et al.,
2017) and availability of plasma chemokines (Novitzky-Basso
and Rot, 2012), EC ACKR1 supports leukocyte trafficking
(Pruenster et al., 2009). The latter was linked with the ability of
EC ACKR1 to facilitate the internalization and transport of tis-
sue-derived chemokines in a basolateral-to-apical manner
across the EC barrier, triggering leukocyte adhesion and trans-
migration through the endothelium (Pruenster et al., 2009).
Such studies involved using exogenous chemokines applied to
either unstimulated tissues or cultured ECs in vitro and under
conditions of ACKR1 overexpression. However, the role of
constitutively expressed ACKR1 in mediating different stages
of neutrophil extravasation in vivo, and most importantly as eli-
cited by endogenous chemokines, has not been addressed
before. A role for ACKR1 in regulation of neutrophil migration is
well in line with its selective expression on venular ECs (Thiriot
et al., 2017), but its EC junctional expression and ability to retain
CXCL2, together with defective neutrophil TEM in EC ACKR1-
deficient mice, revealed a role for ACKR1 in regulation of neutro-
phil TEM. Although we cannot rule out potential contribution of
GAG-bound CXCL2 to ACKR1-dependent and -independent
neutrophil migration through EC junctions, our results suggest
that at sites of inflammation, neutrophils require an EC junctional
ACKR1-dependent depot of neutrophil-derived CXCL2 that
facilitates their directional migration through EC junctions. Of
note, we also found that exogenous CXCL2 can be endocytosed
and localized in discrete vesicles in ECs (in addition to its enrich-
ment within EC junctions), which is consistent with the previously
described role of ACKR1 in chemokine transcytosis (Minten
et al., 2014; Pruenster et al., 2009). This indicates that chemokine
endocytosis and junctional retention are not mutually exclusive
and might occur simultaneously as governed by the nature of
the inflammatory scenario.
Collectively, the present findings offer a diapedesis model
whereby within inflamed venules, ECs and pericytes produce
CXCL1 that is presented to migrating neutrophils on GAG scaf-
folds, thus supporting both luminal and sub-luminal neutrophil
adhesion and crawling responses. With respect to breaching of
the endothelium, we propose that neutrophils that squeeze
through EC junctions secrete CXCL2, which locally binds and
is retained by EC junctional ACKR1. We believe that the
ACKR1-CXCL2 axis provides a potential mechanism whereby
a localized and temporally regulated chemotactic depot sup-
ports TEM through local guidance in an autocrine manner.
Our findings suggest that such compartmentalization of CXCL11074 Immunity 49, 1062–1076, December 18, 2018and CXCL2, and orderly presentation to neutrophils, is critical
in maintaining continued and persistent migration of neutrophils
through venular walls via the same GPCR. Furthermore, while
released chemokines are prone to proteolytic degradation,
neutrophil-derived CXCL2 within the confined region of EC junc-
tions might remain protected from both proteolytic inactivation
and dilution by blood flow. The establishment of an EC junctional
CXCL2 deposition, as mediated via junctional ACKR1, as a
mechanism for supporting neutrophil TEM is reminiscent of the
role of localized EC intracellular CCL2 vesicular depots for sup-
porting lymphocyte TEM (Shulman et al., 2011) and release of
CCL21 at lymphatic EC junctions in supporting dendritic cell
(DC) TEM (Vaahtomeri et al., 2017).
The chemokine superfamily exhibits many examples of
promiscuity, with most chemokine receptors having several
chemokine ligands and many ligands being shared by multiple
receptors. In many scenarios this is believed to offer consider-
able flexibility and redundancy to the system, but there are
also examples where multiple ligands act co-operatively to sup-
port key biological responses. One such scenario is offered by
CCR7 and its ligands CCL19 and CCL21, which show distinct
but co-operative roles in promoting DC migration to secondary
lymphoid tissues (Schumann et al., 2010; Weber et al., 2013).
With respect to CXCR2, although full details of the functional
roles of its multiple ligands are unclear, there is emerging evi-
dence for divergent properties. For example, CXCL1 and
CXCL2 exhibit differential GAG binding dynamics (Tanino et al.,
2010) and human CXCR2 exhibits biased signaling upon ligand
binding (Rajagopal et al., 2013). While these functions suggest
differing biological profiles, the associated mechanisms and
relevance during inflammatory responses in vivo remain unclear.
Our results provide evidence for the existence of distinct but
supportive roles for the CXCR2 ligands CXCL1 and CXCL2 and
show that these properties are tightly regulated by both cell-
intrinsic and -extrinsic factors that cooperate in guiding neutro-
phils through inflamed venular walls. Collectively, these results
support the emerging concept that in inflammatory conditions,
functional gradients are subjected to temporal regulation of che-
mokines that are locally generated and strategically presented to
migrating cells by specialized cellular and extracellular scaffolds.
As such, increased understanding of temporal and localized
generation of inflammatory mediators in distinct disease models
could identify more efficacious and selective modes of targeting
pathological immune cell trafficking.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d CONTACT FOR REAGENT AND RESOURCE SHARING
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
d METHOD DETAILSB Inflammatory response in cremaster muscles
B Whole-mount IF staining
B Confocal microscopy and image analysis
B Peritoneal inflammation
B Flow cytometry
B Confocal intravital microscopy (IVM)
B Neutrophil isolation
B Ca2+ flux assay
B In vitro neutrophil adhesion assay
B Western Blot
B Transwell chemotaxis assay
B Fluorescence in situ hybridization (FISH)
B Pericyte isolation and culture
B Real-time PCR
B In vitro pericyte and neutrophil analysis
B Generation of bone marrow chimeric mice
B Dorsal skin inflammation
B In vivo rmCXCL2 and rmCXCL1 binding assay
d QUANTIFICATION AND STATISTICAL ANALYSES
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and four videos and can be
found with this article online at https://doi.org/10.1016/j.immuni.2018.09.018.
ACKNOWLEDGMENTS
We thank Dr. Christian Weber for providing the anti-MIF mAb. This work was
supported by funds from the British Heart Foundation (FS/14/3/30518 to
T.G. and S.N.), the People Programme (Marie Curie Actions) of the EU’s 7th
Framework Programme (FP7/2007-2013) under REA grant agreement
608765 (to T.G. and S.N.), and by the Wellcome Trust (098291/Z/12/Z to
S.N.). D.S. is supported by the CNIC, SAF2016-79040-R from the Spanish
Ministerio de Ciencia, and ERC-2016-CoG 725091 from the European
Research Council. M.T. and A.R. are supported by the Sinergia grant
CRSII3_160719 of the Swiss National Science Foundation. G.G. is supported
by the Wellcome Trust and the MRC. U.H.v.A. and A.T. are supported by the
Ragon Institute of MGH, MIT and Harvard and the HMS Center for Immune
Imaging.
AUTHOR CONTRIBUTIONS
Conceptualization, writing (original draft), and funding acquisition, T.G., S.N.;
Methodology, T.G., M.-B.V., S.N.; Investigation and formal analysis, T.G.,
T.L., L.P., L.R., A.B., E.L., E.H.; Resources, A.T., C.F., M.T., G.G., D.S.,
U.H.v.A., A.R.; Supervision, R.A., M.-B.V., A.R., S.N.; Writing (review and edit-
ing), all authors.
DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: March 20, 2018
Revised: August 13, 2018
Accepted: September 21, 2018
Published: November 13, 2018
REFERENCES
Armstrong, D.A., Major, J.A., Chudyk, A., and Hamilton, T.A. (2004). Neutrophil
chemoattractant genes KC and MIP-2 are expressed in different cell popula-
tions at sites of surgical injury. J. Leukoc. Biol. 75, 641–648.
Cacalano, G., Lee, J., Kikly, K., Ryan, A.M., Pitts-Meek, S., Hultgren, B.,Wood,
W.I., andMoore, M.W. (1994). Neutrophil andB cell expansion inmice that lack
the murine IL-8 receptor homolog. Science 265, 682–684.
Chou, R.C., Kim, N.D., Sadik, C.D., Seung, E., Lan, Y., Byrne, M.H., Haribabu,
B., Iwakura, Y., and Luster, A.D. (2010). Lipid-cytokine-chemokine cascade
drives neutrophil recruitment in a murine model of inflammatory arthritis.
Immunity 33, 266–278.
Colom, B., Bodkin, J.V., Beyrau, M., Woodfin, A., Ody, C., Rourke, C.,
Chavakis, T., Brohi, K., Imhof, B.A., and Nourshargh, S. (2015). LeukotrieneB4-neutrophil elastase axis drives neutrophil reverse transendothelial cell
migration in vivo. Immunity 42, 1075–1086.
Dawson, T.C., Lentsch, A.B., Wang, Z., Cowhig, J.E., Rot, A., Maeda, N., and
Peiper, S.C. (2000). Exaggerated response to endotoxin in mice lacking the
Duffy antigen/receptor for chemokines (DARC). Blood 96, 1681–1684.
Del Fresno, C., Saz-Leal, P., Enamorado, M., Wculek, S.K., Martı´nez-Cano, S.,
Blanco-Mene´ndez, N., Schulz, O., Gallizioli, M., Miro´-Mur, F., Cano, E., et al.
(2018). DNGR-1 in dendritic cells limits tissue damage by dampening neutro-
phil recruitment. Science 362, 351–356.
Duchene, J., Novitzky-Basso, I., Thiriot, A., Casanova-Acebes, M., Bianchini,
M., Etheridge, S.L., Hub, E., Nitz, K., Artinger, K., Eller, K., et al. (2017). Atypical
chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis.
Nat. Immunol. 18, 753–761.
Faust, N., Varas, F., Kelly, L.M., Heck, S., and Graf, T. (2000). Insertion of
enhanced green fluorescent protein into the lysozyme gene creates mice
with green fluorescent granulocytes and macrophages. Blood 96, 719–726.
Griffith, J.W., Sokol, C.L., and Luster, A.D. (2014). Chemokines and chemokine
receptors: positioning cells for host defense and immunity. Annu. Rev.
Immunol. 32, 659–702.
Hobbs, J.A., May, R., Tanousis, K., McNeill, E., Mathies, M., Gebhardt, C.,
Henderson, R., Robinson, M.J., and Hogg, N. (2003). Myeloid cell function in
MRP-14 (S100A9) null mice. Mol. Cell. Biol. 23, 2564–2576.
Kienle, K., and L€ammermann, T. (2016). Neutrophil swarming: an essential pro-
cess of the neutrophil tissue response. Immunol. Rev. 273, 76–93.
L€ammermann, T., Afonso, P.V., Angermann, B.R., Wang, J.M., Kastenm€uller,
W., Parent, C.A., and Germain, R.N. (2013). Neutrophil swarms require LTB4
and integrins at sites of cell death in vivo. Nature 498, 371–375.
Lefort, C.T., and Ley, K. (2012). Neutrophil arrest by LFA-1 activation. Front.
Immunol. 3, 157.
Li, J.L., Lim, C.H., Tay, F.W., Goh, C.C., Devi, S., Malleret, B., Lee, B.,
Bakocevic, N., Chong, S.Z., Evrard, M., et al. (2016). Neutrophils self-regulate
immune complex-mediated cutaneous inflammation through CXCL2.
J. Invest. Dermatol. 136, 416–424.
Lim, K., Hyun, Y.M., Lambert-Emo, K., Capece, T., Bae, S., Miller, R., Topham,
D.J., and Kim, M. (2015). Neutrophil trails guide influenza-specific CD8+ T cells
in the airways. Science 349, aaa4352.
Minten, C., Alt, C., Gentner, M., Frei, E., Deutsch, U., Lyck, R., Schaeren-
Wiemers, N., Rot, A., and Engelhardt, B. (2014). DARC shuttles inflammatory
chemokines across the blood-brain barrier during autoimmune central ner-
vous system inflammation. Brain 137, 1454–1469.
Nibbs, R.J., and Graham, G.J. (2013). Immune regulation by atypical chemo-
kine receptors. Nat. Rev. Immunol. 13, 815–829.
Nourshargh, S., and Alon, R. (2014). Leukocytemigration into inflamed tissues.
Immunity 41, 694–707.
Nourshargh, S., Hordijk, P.L., and Sixt, M. (2010). Breaching multiple barriers:
leukocytemotility through venular walls and the interstitium. Nat. Rev.Mol. Cell
Biol. 11, 366–378.
Novitzky-Basso, I., and Rot, A. (2012). Duffy antigen receptor for chemokines
and its involvement in patterning and control of inflammatory chemokines.
Front. Immunol. 3, 266.
Phillipson, M., Heit, B., Colarusso, P., Liu, L., Ballantyne, C.M., and Kubes, P.
(2006). Intraluminal crawling of neutrophils to emigration sites: a molecularly
distinct process from adhesion in the recruitment cascade. J. Exp. Med.
203, 2569–2575.
Proebstl, D., Voisin, M.B., Woodfin, A., Whiteford, J., D’Acquisto, F., Jones,
G.E., Rowe, D., and Nourshargh, S. (2012). Pericytes support neutrophil sub-
endothelial cell crawling and breaching of venular walls in vivo. J. Exp. Med.
209, 1219–1234.
Proudfoot, A.E.I., Johnson, Z., Bonvin, P., and Handel, T.M. (2017).
Glycosaminoglycan interactions with chemokines add complexity to a com-
plex system. Pharmaceuticals (Basel) 10, 10.
Pruenster, M., Mudde, L., Bombosi, P., Dimitrova, S., Zsak, M., Middleton, J.,
Richmond, A., Graham, G.J., Segerer, S., Nibbs, R.J., and Rot, A. (2009). TheImmunity 49, 1062–1076, December 18, 2018 1075
Duffy antigen receptor for chemokines transports chemokines and supports
their promigratory activity. Nat. Immunol. 10, 101–108.
Rajagopal, S., Bassoni, D.L., Campbell, J.J., Gerard, N.P., Gerard, C., and
Wehrman, T.S. (2013). Biased agonism as a mechanism for differential
signaling by chemokine receptors. J. Biol. Chem. 288, 35039–35048.
Reglero-Real, N., Colom, B., Bodkin, J.V., and Nourshargh, S. (2016).
Endothelial cell junctional adhesion molecules: role and regulation of expres-
sion in inflammation. Arterioscler. Thromb. Vasc. Biol. 36, 2048–2057.
Sadik, C.D., Kim, N.D., and Luster, A.D. (2011). Neutrophils cascading their
way to inflammation. Trends Immunol. 32, 452–460.
Schumann, K., L€ammermann, T., Bruckner, M., Legler, D.F., Polleux, J., Spatz,
J.P., Schuler, G., Fo¨rster, R., Lutz, M.B., Sorokin, L., and Sixt, M. (2010).
Immobilized chemokine fields and soluble chemokine gradients cooperatively
shape migration patterns of dendritic cells. Immunity 32, 703–713.
Shulman, Z., Cohen, S.J., Roediger, B., Kalchenko, V., Jain, R., Grabovsky, V.,
Klein, E., Shinder, V., Stoler-Barak, L., Feigelson, S.W., et al. (2011).
Transendothelial migration of lymphocytes mediated by intraendothelial
vesicle stores rather than by extracellular chemokine depots. Nat. Immunol.
13, 67–76.
Stadtmann, A., and Zarbock, A. (2012). CXCR2: From bench to bedside. Front.
Immunol. 3, 263.
Tanino, Y., Coombe, D.R., Gill, S.E., Kett, W.C., Kajikawa, O., Proudfoot, A.E.,
Wells, T.N., Parks, W.C., Wight, T.N., Martin, T.R., and Frevert, C.W. (2010).
Kinetics of chemokine-glycosaminoglycan interactions control neutrophil
migration into the airspaces of the lungs. J. Immunol. 184, 2677–2685.1076 Immunity 49, 1062–1076, December 18, 2018Tecchio, C., and Cassatella, M.A. (2016). Neutrophil-derived chemokines on
the road to immunity. Semin. Immunol. 28, 119–128.
Thiriot, A., Perdomo, C., Cheng, G., Novitzky-Basso, I., McArdle, S.,
Kishimoto, J.K., Barreiro, O., Mazo, I., Triboulet, R., Ley, K., et al. (2017).
Differential DARC/ACKR1 expression distinguishes venular from non-venular
endothelial cells in murine tissues. BMC Biol. 15, 45.
Vaahtomeri, K., Brown, M., Hauschild, R., De Vries, I., Leithner, A.F., Mehling,
M., Kaufmann, W.A., and Sixt, M. (2017). Locally triggered release of the che-
mokine CCL21 promotes dendritic cell transmigration across lymphatic endo-
thelia. Cell Rep. 19, 902–909.
Wang, S., Voisin, M.B., Larbi, K.Y., Dangerfield, J., Scheiermann, C., Tran, M.,
Maxwell, P.H., Sorokin, L., and Nourshargh, S. (2006). Venular basement
membranes contain specific matrix protein low expression regions that act
as exit points for emigrating neutrophils. J. Exp. Med. 203, 1519–1532.
Weber, M., Hauschild, R., Schwarz, J., Moussion, C., de Vries, I., Legler, D.F.,
Luther, S.A., Bollenbach, T., and Sixt, M. (2013). Interstitial dendritic cell guid-
ance by haptotactic chemokine gradients. Science 339, 328–332.
Woodfin, A., Voisin, M.B., Beyrau, M., Colom, B., Caille, D., Diapouli, F.M.,
Nash, G.B., Chavakis, T., Albelda, S.M., Rainger, G.E., et al. (2011). The junc-
tional adhesion molecule JAM-C regulates polarized transendothelial migra-
tion of neutrophils in vivo. Nat. Immunol. 12, 761–769.
Zhang, X.W., Liu, Q., Wang, Y., and Thorlacius, H. (2001). CXC chemokines,
MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravas-
cular migration in vivo. Br. J. Pharmacol. 133, 413–421.
Zlotnik, A., and Yoshie, O. (2012). The chemokine superfamily revisited.
Immunity 36, 705–716.
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Anti-mouse MRP14 (clone 2B10) Gift from Dr N. Hogg (Cancer
Research UK UK) (Hobbs
et al., 2003)
NA
Anti-mouse a-SMA (clone 1A4) Sigma-Aldrich Cat#A5228; RRID: AB_262054
Anti-mouse CD31 (clone 390) Thermo Fisher Scientific Cat#16-0311-85; RRID: AB_468933
Anti-mouse VE-Cadherin (clone eBioBV14) Thermo Fisher Scientific Cat#14-1442-85; RRID: AB_891373
Anti-mouse ACKR1 (clone 6B7) (Thiriot et al., 2017) NA
Anti-mouse PDGFR-b (polyclonal) R&D Systems Cat#AF1042; RRID: AB_2162633
Anti-mouse NG2 (polyclonal) Millipore Cat#AB5320; RRID: AB_91789
Blocking anti-mouse CXCL1 (clone 48415) R&D Systems Cat#MAB453; RRID: AB_2087696
Blocking anti-mouse CXCL2 (clone 40605) R&D Systems Cat#MAB452; RRID: AB_2230058
Anti-mouse CXCL1 (polyclonal) R&D Systems Cat#AF-453-NA; RRID: AB_354495
Anti-mouse CXCL2 (polyclonal) R&D Systems Cat#AF-452-NA; RRID: AB_2086326
Blocking anti-mouse CXCL5 (clone 61905) R&D Systems Cat#MAB433; RRID: AB_2086587
Blocking anti-mouse MIF (clone CT 1C10) Gift from Dr C. Weber (Ludwig
Maximilians University Munich,
Germany)
NA
Blocking anti-mouse CXCR2 (clone 242216) R&D Systems Cat#MAB2164; RRID: AB_358062
Alexa Fluor 647 anti-mouse CXCR2 (clone SA044G4) Biolegend Cat#149306; RRID: AB_2565694
Pacific Blue anti-mouse CD45 (clone 30-F11) Biolegend Cat#103126; RRID: AB_493535
Alexa Fluor 647 anti-mouse Ly6G (clone 1A8) Biolegend Cat#127610; RRID: AB_1134159
PE anti-mouse CD115 (clone AFS98) Thermo Fisher Scientific Cat#12-1152-83: RRID: AB_465809
Anti-pan-AKT (polyclonal) Cell Signaling Technology Cat#9272; RRID: AB_329827
Anti-phospho-AKT (clone D9E) Cell Signaling Technology Cat#4060; RRID: AB_2315049
Chemicals, Peptides, and Recombinant Proteins
BSA, low endotoxin Sigma-Aldrich Cat#A9543
Bovine collagen type I Advanced Biomatrix Cat#5005
DMEM, low glucose Thermo Fisher Scientific Cat#11885084
Fluo-4, AM, cell permeant Thermo Fisher Scientific Cat#F14201
HALT protease and phosphatase inhibitor cocktail Thermo Fisher Scientific Cat#78440
LPS Sigma-Aldrich Cat#L4391
LTB4 Cayman Chemical Cat#20110
Pluronic F-127 Thermo Fisher Scientific Cat#P3000MP
Probenecid, water soluble Thermo Fisher Scientific Cat#P36400
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NA
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Real-time PCR primer: Cxcl1 reverse
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Real-time PCR primer: Cxcl2 forward
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Chemotaxis and migration tool v2.0 IBIDI https://ibidi.com/manual-image-analysis/
171-chemotaxis-and-migration-tool.html
FlowJo v10.2 Tree Star https://www.flowjo.com/
ImageJ 1.49 NIH https://imagej.nih.gov/ij/
Imaris v8 Bitplane http://www.bitplane.com/imaris
Prism v6.05 GraphPad https://www.graphpad.com/scientific-
software/prism/
Other
Corning Transwell inserts Sigma-Aldrich Cat#CLS3415-48EA
123count eBeads counting beads Thermo Fisher Scientific Cat#01-1234-42CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Sussan
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academics indicated in parenthesis: Anti-ACKR1 mAb (Dr Ulrich H von Andrian), Lyz2-EGFP-ki mice (Dr Thomas Graf) and Acta2-
RFPcherry-Tg mice (Dr David Rowe).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
WT C57BL/6 mice were purchased from Charles River Laboratories, UK. The Lyz2-EGFP-ki mouse colony was kindly provided by
Dr Markus Sperandio (Ludwig Maximilians University of Munich, Germany) and used with the permission of Dr Thomas Graf (Center
for Genomic Regulation and ICREA, Spain). These mice contain an EGFP gene that was knocked into the lysozymeM (Lyz2) locus to
generateGFP+myeloid cells (GFPbright neutrophils, GFPdimmonocytes andmacrophages) andwere backcrossedwith C57BL/6mice
for at least 8 generations (Faust et al., 2000). Acta2-RFPcherry-Tg mice were previously generated on a C57BL/6 background (Pro-
ebstl et al., 2012) and contain a transgenic insertion of the RFP variant cherry under control of the Acta2 promotor and express RFP+
pericytes and smooth muscle cells. The Lyz2-EGFP-ki;Acta2-RFPcherry-Tg colony was obtained by crossing the Lyz2-EGFP-ki col-
ony with the Acta2-RFPcherry-Tg colony (Proebstl et al., 2012). Ackr1/ mice (Dawson et al., 2000) and Cxcr2/ mice (Cacalano
et al., 1994) were backcrossed onto a C57BL/6 background for at least 11 generations.Cxcr2/ andWTmice exhibited similar levels
of circulating neutrophils as determined 4 hr after i.s. TNF injection (1135 and 1723 neutrophils/ml blood respectively, p > 0.5, n = 7-8
mice per group). The Cxcl2/mice on C57BL/6 background were generated from heterozygotes from The Jackson Laboratory and
were bred at the CNIC under specific pathogen-free (SPF) conditions (Del Fresno et al., 2018). All animals were group housed in indi-
vidually ventilated cages under SPF conditions at theWilliam Harvey Research Institute, Queen Mary University of London, UK. Male
mice were used for studying responses in the cremaster muscle and dorsal skin and female mice were used for peritonitis experi-
ments and analyses of the dermal ear vasculature. All experiments were carried out using 8-12-week-old mice (age and sexmatched
groups) and were performed in accordance with the UK Home Office legislation.
METHOD DETAILS
Inflammatory response in cremaster muscles
Mice were anaesthetized with 3% isoflurane and injected i.s. with 300 ng TNF or 50 ng IL-1b (both R&D Systems), whereas control
mice received 400 ml PBS (2-4 hr incubation). For the analysis of total neutrophil extravasation blocking anti-CXCL1, anti-CXCL2,
anti-CXCL5 (all R&D Systems) or anti-MIF mAbs (kindly provided by Dr Christian Weber, Ludwig Maximilians University of Munich,
Germany) or corresponding isotype control mAbs (30 mg/mouse, R&D Systems) were injected i.s. together with TNF. For IVM ana-
lyses mAbs were applied as described in the corresponding section below.
Whole-mount IF staining
Cremastermuscles or ears were fixed in 4%paraformaldehyde (PFA, Sigma-Aldrich) for 1 hr at 4Cand permeabilized and blocked in
PBS containing 0.5% Triton X-100 (Sigma-Aldrich) and 25% fetal calf serum (FCS, Thermo Fisher Scientific) for 4 hr at room temper-
ature. Subsequently, the tissues were incubated with unlabeled or fluorescently labeled primary antibodies in PBS containing 10%
FCS over night at 4C. Where required, samples were incubated with fluorescently labeled secondary antibodies in PBS containing
10%FCS for 3 hr at room temperature. Antibody conjugation to Alexa Fluor 488, 555, 647 or DyLight 405 fluorophoreswas carried out
using labeling kits (Thermo Fisher Scientific) according to the manufacturer’s recommendations.
Confocal microscopy and image analysis
Immunostained whole-mount cremaster muscles or ears were imaged with an up-right Leica TCS SP5 (Leica) or inverted Zeiss 800
(Carl Zeiss) confocal laser scanning microscope equipped with argon and helium lasers (488, 561 and 633 nm excitation wave-
lengths) or solid-state laser diodes (405, 488, 561 and 640 nm excitation wavelengths), respectively. Serial z stacks of postcapillary
venules (diameter 20-45 mm) were acquired with a water dipping 20x (1 NA) objective or oil immersion 40x (1.3 NA) or 63x (1.4 NA)
objectives and the resulting images of half vessels were reconstructed in 3D and analyzed using Imaris software (Bitplane). Neutrophil
extravasation in cremaster muscles was determined by immunostaining using mAbs against MRP14 (kindly provided by Dr Nancy
Hogg, Cancer Research UK, UK), CD31 (Thermo Fisher Scientific) and a-SMA (Sigma-Aldrich) to label neutrophils, ECs and peri-
cytes, respectively. Extravasated neutrophils per field of view (330 3 160 3 45 mm) were quantified from 8-10 images per mouse.
Cxcl2/ and GFP-Cxcl2wt/wt neutrophils in mixed chimeric mice were identified based on their MRP14+/GFP- and MRP14+/GFP+
expression profile, respectively, and normalized for neutrophil numbers in the blood. Adherent neutrophils in Cxcl2/ chimeras
were determined by IF staining and defined as luminal neutrophils attached to ECs. Endogenous chemokine expression or rmCXCL1
or rmCXCL2 binding within venular ECs and pericytes was analyzed using polyclonal anti-CXCL1 or anti-CXCL2 antibodies (R&D
Systems) as described (Woodfin et al., 2011). Briefly, EC and pericyte isosurfaces were created based on regions immunostained
for CD31 (including CD31high junctional and CD31dim non-junctional regions) or a-SMA, respectively, and chemokine MFI values
per unit area within these isosurfaces were determined. The pericyte marker expression profile was established using anti-
a-SMA, anti-PDGFR-b (R&D Systems), and anti-NG2 (Millipore) antibodies. ACKR1 expression was determined using mAbs specific
for ACKR1 (Thiriot et al., 2017), VE-Cadherin (Thermo Fisher Scientific) and CD31. Where indicated endothelial ACKR1 and chemo-
kine MFI values were quantified within EC-junctions (isosurface created on CD31high or VE-Cadherin+ regions) or non-junctional re-
gions (isosurface on CD31dim/VE-Cadherin- regions). All protein expression levels were quantified from 4-10 images per mouse andImmunity 49, 1062–1076.e1–e6, December 18, 2018 e3
expressed as MFI values per unit area of tissues stained with specific antibodies subtracted by MFI values per unit area of tissues
stained with appropriate isotype controls. All images used for protein and mRNA (FISH) quantifications were captured with the 63x
objective in themultiple track scanningmode every 0.43 mmat a resolution of 10243 512 mmcorresponding to a voxel size of 0.0993
0.099 3 0.43 mm in x 3 y 3 z, respectively. The fluorescence intensity line profiles were determined using ImageJ software (NIH).
Peritoneal inflammation
Peritonitis was induced by intraperitoneal (i.p.) injections of 300 ng TNF in WT mice or Cxcl2/, Ackr1/ or corresponding control
chimeras, whereas non-inflamed control mice received 1 mL of PBS. Blocking anti-CXCL1, anti-CXCL2, anti-CXCR2 mAbs (R&D
Systems) or corresponding isotype control mAbs (3 mg/kg, R&D Systems) were administered i.v. 10 min prior to TNF. 4 hr after
TNF or PBS administration, mice were culled and subjected to peritoneal lavages using 5 mL PBS containing 5 mM EDTA
(Sigma-Aldrich) and 0.25% BSA. The peritoneal exudates were stained for the leukocyte marker CD45, the neutrophil marker
Ly6G (both Biolegend) and the monocyte and macrophage marker CD115 (Thermo Fisher Scientific) and total numbers of infiltrating
neutrophils and monocytes per peritoneal cavity were determined by flow cytometry.
Flow cytometry
Where required, samples were treated with ACK buffer (150 mM NH3Cl, 1 mM KHCO3 and 1 mM EDTA) to lyse red blood cells. Sub-
sequently, the samples were incubated with anti-CD16/-CD32 antibodies (Becton Dickinson) to block Fc-receptors and stained with
primary fluorescently labeled antibodies of interest. CXCR2 surface levels on neutrophils were determined with an anti-CXCR2 mAb
(Biolegend). The samples were analyzed on an LSR Fortessa flow cytometer (Becton Dickinson) and FlowJo software (TreeStar). To-
tal neutrophil numbers in samples were determined using fluorescent counting beads (Thermo Fisher Scientific).
Confocal intravital microscopy (IVM)
The mode and dynamics of neutrophil migration through blood vessel walls was analyzed by confocal IVM, as described previously
(Proebstl et al., 2012; Woodfin et al., 2011). In order to analyze neutrophil interactions with ECs and pericytes simultaneously Lyz2-
EGFP-ki;Acta2-RFPcherry-Tg mice (exhibiting GFP+ neutrophils and RFP+ pericytes), were injected i.s. with an Alexa Fluor 647-
labeled non-blocking anti-CD31 mAb (4 mg, clone 390, Thermo Fisher Scientific) to stain EC junctions (2 h). Alternatively, IVM was
performed on bone marrow chimeric mice exhibiting Lyz2-EGFP-ki hematopoietic (GFP+ neutrophils) and Ackr1/ or WT non-he-
matopoietic cells, which received i.s. injections of an Alexa Fluor 555-anti-CD31 mAb (clone 390).
2 hr after i.s. administration of 300 ng TNF, 50 ng IL-1b or 400 ml PBS themicewere anaesthetized by i.p. administration of ketamine
(100 mg/kg) and xylazine (10 mg/kg) and the cremaster muscles were exteriorized and pinned out flat over the optical window of a
heated custom-built microscope stage. The animals were maintained at 37C and the cremaster muscles were perfused with 37C
warm Tyrode’s solution (Sigma-Aldrich) during the experiment. Blocking anti-CXCL1, anti-CXCL2 or isotype control mAbs (3 mg/kg)
were injected i.v. 10min before i.s. TNF administration for the analysis of intraluminal and TEM neutrophil responses as indicated. For
the analysis of TEM and post-TEM neutrophil responses the mAbs (30 mg) were injected i.s. 100 min after TNF administration. Post-
capillary venules with a diameter of 20-45 mm were recorded for 0.5-2 hr using an upright Leica SP5 confocal laser scanning micro-
scope and a 20x water-dipping objective (NA 1.0). Serial z stack images were acquired every 30 or 60 s and assembled offline into 3D
videos using Imaris software. The dimension of the recorded area was typically 3003 1303 35 mm and the resulting voxel size was
0.293 0.293 0.69 mm in x3 y3 z. Models of half vessel were generated to clearly visualize individual neutrophils migrating through
the different compartments of venular walls. Neutrophil migrationmode and dynamics (speed and displacement) were determined by
manual tracking of individual neutrophils using Imaris software andmigratory paths were graphically illustrated using the Chemotaxis
and migration tool (IBIDI). Luminal neutrophils were defined as adherent when they remained stationary on the endothelium for at
least 30 s and as intraluminally crawling when they exhibited a displacement of at least 2 cell diameters on the endothelium over
the entire observation period. The numbers of adherent and crawling neutrophils were expressed as means determined at 4 time
points per mouse. Neutrophil TEM was defined as an event where neutrophils fully migrated through EC junctions in a luminal-to-
abluminal direction. Aborted TEMwas classified as a response where luminal neutrophils extended protrusions through EC junctions
(but did not exhibit complete TEM) and subsequently reverse migrated in an abluminal-to-luminal direction and finally disengaged
from the EC junction and re-entered the vascular lumen. Reverse neutrophil TEM was a response where sub-EC neutrophils (after
having fully breached the endothelium) migrated through an EC junction in an abluminal-to-luminal direction. TEM, aborted TEM
and reverse TEM events were quantified over the entire IVM observation period of 2 h.
Neutrophil isolation
Murine neutrophils were isolated frombonemarrow cells (harvested from tibiae and femora) or peripheral blood by negativemagnetic
cell sorting using the Neutrophil isolation kit (Miltenyi Biotec) according to the manufacturer’s instructions. The purity of isolated neu-
trophils (CD45+/Ly6G+/CD115- expression profile) was consistently > 95% as determined by flow cytometry.
Ca2+ flux assay
Up to 10 3 106 isolated bone marrow neutrophils from WT C57BL/6 mice were suspended in 1 mL RPMI-1640 medium (Sigma-Al-
drich) supplemented with 5%FCS, 2mML-glutamine, 1 g/L NaHCO3, and 20mMHEPES and incubated with 4 mMof the fluorescent
Ca2+ indicator Fluo-4, 0.04% Pluronic F-127 and 1 mM Probenecid (all Thermo Fisher Scientific) for 45 min at 37C. The neutrophilse4 Immunity 49, 1062–1076.e1–e6, December 18, 2018
were then washed and analyzed by flow cytometry at room temperature. Specifically, Fluo-4 fluorescence readings (excitation wave-
length: 488 nm, 530/30 nm bandpass filter) were recorded for 30 s to establish a baseline and for 3 min after the addition of CXCL1 or
CXCL2 (Preprotech). Results show baseline corrected Fluo-4MFI or peak fluorescence values as determined using FlowJo software.
In vitro neutrophil adhesion assay
96 well plates were coated with 2.5 mg/mL ICAM-1 (R&D Systems) over night at 4C and blocked with 10% low endotoxin BSA
(Sigma-Aldrich) for 2 hr at room temperature. Isolated bone marrow neutrophils were added, and the plates were centrifuged at
20 g for 2 min and treated with CXCL1, CXCL2 or control medium for 15 min at 37C. Non-adherent cells were then washed
away with PBS containing 1 mM CaCl2, 0.5 mM MgCl2. Subsequently, adherent neutrophils were detached by TrypLE express
cell detachment solution (Thermo Fisher Scientific) and quantified by flow cytometry. The results were expressed as the percentage
of adherent neutrophils after chemokine addition, subtracted by the percentage of adherent neutrophils in the absence of
chemokines.
Western Blot
Isolated neutrophils were lysed in 1x Laemmli Buffer, denatured at 95C and subjected to standard Western Blot analysis using anti-
pan-AKT and anti-phospho-AKT primary antibodies (Cell Signaling Technology) and a horseradish peroxidase-conjugated second-
ary antibody (Dako). Proteins were visualized by enhanced chemiluminescence acquired on X-ray film (Fuji Medical) and quantified
by ImageJ software.
Transwell chemotaxis assay
Bone marrow neutrophils from Lyz2-EGFP-ki mice or mixed Cxcl2/-Cxcl2wt/wt chimeric mice were seeded into top chambers of
Transwell plates (3 mm pore diameter, Sigma-Aldrich) in PBS supplemented with 1 mM CaCl2, 0.5 mM MgCl2, 10 mM glucose,
10 mM HEPES (Sigma Aldrich) and 0.25% low endotoxin BSA. In some experiments, Transwell filters were coated with 0.5 mg/mL
CXCL1 or CXCL2 in PBS or with PBS alone over night at 4C and blocked with 10% low endotoxin BSA for 1 hr at room temperature
before adding neutrophils. Where indicated 10 nM CXCL1 or CXCL2 were added to the top chamber with the neutrophils. 0-10 nM
CXCL1, CXCL2 or leukotriene B4 (LTB4, Cayman Chemical) were added to the bottom chambers and the Transwell plates were incu-
bated for 1 hr at 37C. Neutrophils migrated into the bottom chambers were resuspended in PBS containing 5 mM EDTA and their
absolute numbers were determined by flow cytometry.GFP-Cxcl2wt/wt andCxcl2/ neutrophils were identified by their Ly6G+/GFP+
or Ly6G+/GFP- expression profile, respectively. Confocal microscopy was used to assess chemokine immobilization on Transwell
filters by immunostaining and to analyze neutrophil morphology.
Fluorescence in situ hybridization (FISH)
Cremaster muscles were frozen and cut into 30 mm sections. In situ hybridization was carried out using the RNAscope fluorescent
multiplex assay (Advanced Cell Diagnostics) according to themanufacturer’s instruction with slight modifications. Briefly, after dehy-
dration the sections were incubated with Pretreat 4 for 20 min at room temperature and hybridized with probes for Pecam1, Acta2,
Cxcl1 and Cxcl2mRNAs for 2 hr at 40C. To evaluate the assay, sections were hybridized with probes for Ppib (positive control) and
DapB (negative control). The amplification steps were performed according to the RNAscope protocol. Where required, in situ hy-
bridization procedure was directly followed by IF staining with an anti-a-SMA antibody over night at 4C. Fluorescent mRNA spots
and IF stainings were visualized by confocal microscopy. Cxcl1 and Cxcl2 mRNA copy numbers in microvascular walls were deter-
mined by automatic quantification of fluorescent spots within Pecam1- and Acta2-positive regions using Imaris software. Within this
assay, as detailed in the manufacturer’s guidelines, each mRNA molecule hybridized to a probe appears as single fluorescent spot.
At least 6 vessel segments per mouse were analyzed.
Pericyte isolation and culture
Cremaster muscles from Acta2-RFPcherry-Tg mice were digested with 500 U/mL Collagenase II (Worthington) in PBS for 45 min at
37C and 50 U/mL DNase I (Sigma-Aldrich) was added during the last 20 min. The resulting cell suspension was seeded onto tissue
culture plates coated with gelatin and collagen I (Advanced BioMatrix) and cultured in low glucose Dulbecco’s Modified Eagle’s Me-
dium (DMEM) supplemented with 10% FCS, 100 U/mL penicillin, 100 mg/mL streptomycin (all Thermo Fisher Scientific) and 100 pM
pigment epithelium-derived factor (PEDF, Sigma-Aldrich). After21 days of culture, confluent cells were detached with 5 mM EDTA
and cells exhibiting the unique venular pericyte signature (a-SMA+PDGFR-b+NG2-) were isolated using the FACSCalibur cell sorter
(Becton Dickinson). a-SMA+ cells were identified by RFP expression. Pericytes showing > 90% purity were subjected to further
analyses.
Real-time PCR
Total RNA was purified from isolated murine peripheral blood neutrophils or cultured lung ECs or cremaster muscle pericytes using
the RNeasy micro kit (Quiagen) and reverse transcribed into cDNA with the iScript cDNA synthesis kit (Biorad). Quantitative real-time
PCR was carried out using the iQ SYBR Green supermix (Biorad) according to the manufacturer’s protocol, primers for Cxcl1, Cxcl2
and Gapdh (Integrated DNA Technologies) and the 7900HT real-time PCR machine (Applied Biosystems). Cxcl1 and Cxcl2 mRNA
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In vitro pericyte and neutrophil analysis
Cultured murine primary cremaster muscle pericytes were seeded onto gelatin- and collagen I-coated plates and activated with TNF
in DMEM low glucose medium containing 10% FCS and 100 U/mL penicillin and 100 mg/mL streptomycin for 4 hr at 37C. Alterna-
tively, isolated bone marrow neutrophils were stimulated with 1 nM TNF in PBS containing 1 mM CaCl2, 0.5 mM MgCl2, 10 mM
glucose, 10 mM HEPES and 0.25% low endotoxin BSA for 1 hr at 37C. For some experiments, neutrophils were seeded on wells
that were coated with 2.5 mg/mL CXCL1 or PBS over night at 4C and blocked with 10% endotoxin low BSA for 1 hr at room tem-
perature. Supernatants of pericyte and neutrophil cultures were taken at the end of the stimulation periods and the cells were lysed
with 1% Triton X-100 in PBS containing HALT protease and phosphatase inhibitor (Thermo Fisher Scientific). Chemokine levels were
determined by ELISA kits (R&D Systems, sensitivity: 2 pg/mL for CXCL1 and 1.5 pg/mL for CXCL2).
Generation of bone marrow chimeric mice
Mice exhibiting CXCL2-deficiency in the hematopoietic compartment andWT control chimeras were generated by transferring bone
marrow cells from Cxcl2/ or WT mice into Lyz2-EGFP-ki mice. Mixed Cxcl2/-Cxcl2wt/wt chimeras were established by transfer-
ring a 1:1 mixture of bone marrow cells from Cxcl2/ and Lyz2-EGFP-kimice into Lyz2-EGFP-kimice.GFP-Cxcl2wt/wt neutrophils in
mixed chimeras were distinguished from Cxcl2/ neutrophils based on their GFP expression. Mice exhibiting GFP+ myeloid cells
and Ackr1/ or WT non-hematopoietic cells were generated by transferring bone marrow cells from Lyz2-EGFP-ki mice into
Ackr1/ or WT recipients. To generate the chimeras, recipient mice were lethally irradiated with 2 doses of 5 Gy given 4 hr apart.
The following day 1.5 3 106 bone marrow cells from donor mice were injected i.v. into the irradiated mice. The chimeras were sub-
jected to IVM analyses 4weeks after bonemarrow transplantation. Control experiments confirmed thatCxcl2/ chimeras andmixed
Cxcl2/-Cxcl2wt/wt chimeras showed normal circulating neutrophil numbers compared to WT control chimeras (2442, 2509 and
2410 neutrophils/ml blood, respectively, p > 0.5, n = 11-20 mice per group). Ackr1/ and WT chimeras expressed similar levels
of CXCR2 on circulating neutrophils (MFI of 1100 and 975, respectively, p > 0.5, n = 3 mice per group), as determined 3 hr after
i.s. injection of TNF.
Dorsal skin inflammation
TNF, LPS (Sigma-Aldrich, both 300 ng in 50 ml volumes) or PBS were injected intradermally into the dorsal skin of Cxcl2/, Ackr1/
or corresponding WT control chimeric mice. After 4 h, skin samples were dissected, frozen in liquid nitrogen and homogenized in
homogenization buffer (600 mM NaCl, 0.5% hexadecyltrimethylammonium bromide buffer, 600 mM KH2PO4, 66 mM Na2HPO4) us-
ing a Precellys instrument (Bertin Technologies). Tissue debris was removed by centrifugation. The peroxidase activity in the super-
natants was determined by adding the MPO substrate 3,30,5,50-tetramethylbenzidine (Invitrogen) and measuring the absorbance at
650 nm over 20 min using a Spectra MR photometer (Dynex technologies). The MPO activity (used as a readout for neutrophil infil-
tration) was expressed as the increase in optical density per min multiplied by 100.
In vivo rmCXCL2 and rmCXCL1 binding assay
RmCXCL2 or rmCXCL1 (both 0.5 mg) were injected i.s. into WT or Ackr1/ mice together with an Alexa Fluor 488-anti-CD31 mAb
(4 mg). After 2 h, the mice were culled, and the cremaster muscles were dissected, rinsed in cold PBS, fixed with 4% PFA, permea-
bilized and blocked with 0.5% Triton X-100 and 25% FCS in PBS and immunostained using antibodies specific for CXCL2 or CXCL1,
MRP14 and VE-Cadherin or ACKR1. Subsequently, the tissues were analyzed by confocal microscopy. The biological activity of in-
jected rmCXCL1 and rmCXCL2 was verified by intense neutrophil infiltration (not shown) and the binding capacity of rmCXCL1 was
indicated via detection on extravascular cells (Figure S5E).
QUANTIFICATION AND STATISTICAL ANALYSES
Statistical analyses were performed using Prism software (GraphPad). The results are expressed as means ± SEM and the exact n
numbers for each dataset is provided in the Figure legends. Comparisons between two groups were carried out using the paired or
unpaired Student’s t test or Fisher’s exact test as appropriate. One-way ANOVA followed by Bonferroni post hoc test or two-way
ANOVA with Holm Sidak’s post hoc test were performed for multiple group comparisons. Differences between dose-response
curves were evaluated with the extra-sum-of-squares F test. Statistical significance was accepted at p < 0.05.e6 Immunity 49, 1062–1076.e1–e6, December 18, 2018
